腹部放射学会疾病聚焦小组调查:偶发胰腺囊性病变管理建议的临床使用与模板报告
该调查向腹部放射学会成员发放匿名问卷,评估偶发胰腺囊性病变随访方案、管理指南及模板报告的使用现状。323名应答者中42.5%首选2017 ACR建议,68.7%认为制定单一国际共识很重要,但标准化报告模板使用率仅12.8%。
要点
- 2017 ACR建议是首选管理方案(42.5%),但家庭自制系统(17.8%)和Fukuoka指南(15.0%)也有使用。
- MR cholangiopancreatography是<2.5 cm囊肿随访的首选 modality,69.7%常规使用静脉对比剂。
- 标准化报告模板使用率极低(12.8%),尽管多数放射科医生希望在报告中包含管理建议。
诊断标准与关键数值
- 42.5%(136/320)首选2017 ACR建议,17.8%(57/320)使用自制系统,15.0%(48/320)使用Fukuoka指南,7.8%(25/320)使用AGA指南。
- 68.7%(222/323)同意或强烈同意制定单一国际共识管理建议很重要。
- 71.7%(231/322)的放射科医生倾向于在报告中包含管理建议,但仅半数(161/321)在超过75%的报告中包含建议。
- MRI cholangiopancreatography是<2.5 cm囊肿随访的首选检查方式。
- 69.7%(212/304)常规使用静脉对比剂;标准化报告模板使用率仅12.8%(39/306)。
临床应用与阅片要点
- 日常阅片遇到偶发胰腺囊性病变时,可参考2017 ACR建议进行随访管理,但需注意不同机构可能采用自制系统或Fukuoka指南。
- 对于<2.5 cm的囊肿,随访首选MR cholangiopancreatography,多数医生常规使用静脉对比剂。
- 尽管多数医生希望在报告中包含管理建议,但实际执行率不高,且标准化模板使用率低,提示报告规范化仍有提升空间。
局限性
- 调查基于自愿应答,可能存在应答偏倚。
- 应答者主要来自北美学术机构,结果可能不代表全球或非学术机构实践。
- 问卷发放于2018年,指南推荐和临床实践可能已发生变化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To assess current practice patterns with respect to protocols used for incidental pancreatic cyst follow-up, management guidelines, and template reporting.
METHODS: The Society of Abdominal Radiology Disease Focused Panel on intraductal pancreatic neoplasms distributed an anonymous 14-question survey to its members in June 2018 that focused on current utilization of incidental pancreatic cyst guidelines, protocols, and template reporting.
RESULTS: Among the 1,390 email invitations, 323 responded, and 94.7% (306 of 323) completed all questions. Respondents were mainly radiologists (93.8%, 303 of 323) from academic institutions (74.7%, 227 of 304) in North America (93.7%, 286 of 305). Of respondents, 42.5% (136 of 320) preferred 2017 ACR recommendations, 17.8% (57 of 320) homegrown systems, 15.0% (48 of 320) Fukuoka guidelines, and 7.8% (25 of 320) American Gastroenterological Association guidelines. The majority (68.7%, 222 of 323) agreed or strongly agreed that developing a single international consensus recommendation for management was important, and most radiologists preferred to include them in reports (231 of 322, 71.7%); yet only half included recommendations in >75% of reports (161 of 321). MR cholangiopancreatography was the modality of choice for follow-up of <2.5 cm cysts. Intravenous contrast was routinely used by 69.7% (212 of 304). Standardized reporting templates were rarely used in practice (12.8% 39 of 306).
CONCLUSIONS: Nearly 7 of 10 radiologists desire a unified international consensus recommendation for management of incidental cystic pancreatic lesions; ACR 2017 recommendations are most commonly used, followed by homegrown systems and Fukuoka guidelines. The majority of radiologists routinely use MR cholangiopancreatography with intravenous contrast for follow-up of incidental cystic lesions, but template reporting is rarely used.
引用
- Luk L, Hecht EM, Kang S, et al. Society of Abdominal Radiology Disease Focused Panel Survey on Clinical Utilization of Incidental Pancreatic Cyst Management Recommendations and Template Reporting. J Am Coll Radiol. 2021. PMID: 34004175. doi:10.1016/j.jacr.2021.04.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。